Usa India hospital covid-19 pandemic medicines Usa India

Lupin’s Q1 net profit falls 59% YoY as covid-19, lockdowns drag India, US sales

Reading now: 171
www.livemint.com

₹108.2 crore as the covid-19 pandemic and the lockdowns imposed to curb it dragged sales of its medicines in India and US.The company’s consolidated revenue from operations were down 9% at ₹3,529 crore, with operating margins contracting 530 basis points (bps) to 14.7% in the quarter.

However, the margins were up 90 bps on a quarter-on-quarter basis.“The quarter’s performance was impacted by the covid-19 pandemic and related lockdowns, affecting our key businesses in India and US," Lupin managing director Nilesh Gupta said in a statement.“Despite the challenges impacting revenues, we improved margins driven by tight expense control.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA